This measure estimates hospital risk standardized odds ratio for death from all causes within 30 days following transcatheter aortic valve replacement. The measure uses clinical data available in the STS/ACC TVT Registry for risk adjustment. For the purpose of development and testing, the measure used site-reported 30-day follow-up data contained in the STS/ACC TVT Registry.
-
-
1.14 Numerator
The outcome of this measure is all-cause death within 30 days following a transcatheter aortic valve replacement (TAVR).
-
1.15 Denominator
The target population for the outcome is for individuals who have undergone transcatheter aortic valve replacement.
For development, reassessment and reporting of this measure, we use site reported data from the STS/ACC TVT Registry.
-
Exclusions
1) Hospitals need to meet eligibility criteria to be included in the measure.
2) Patients are excluded if:
a) They did not have a first-time TAVR in the episode of care (admission),
b) The TAVR was subsequent to another procedure in the Registry (other TAVR, Mitral Leaflet Clip and/or TMVR) during that admission.
c) The patient is readmitted for a repeat TAVR (re-admission) and the initial TAVR was performed during the rolling 3-year timeframe for the measure.
d) 30-day mortality status missing.
-
1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityEndorsed Cardiovascular Fall Cycle 2019Initial EndorsementLast Updated
-
StewardSteward Organization EmailSteward Organization Copyright
American College of Cardiology Foundation All Rights Reserved
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)
-
Planned Use
-